Purple Biotech Ltd. American Depositary Shares (PPBT) Stock Price, Quote & AI Analysis

Live PPBT stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Purple Biotech Ltd. American Depositary Shares.

TradeVae provides AI-driven analysis and real-time market intelligence for Purple Biotech Ltd. American Depositary Shares (PPBT), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

P
PPBT
Purple Biotech Ltd. American Depositary Shares
real-time
$0.00 +0.00 (+0.00%)
Open
0.000000
High
0.000000
Low
0.000000
Volume
0
VWAP
-
Market Cap
$5,766,844.73
52W Range
$3.60 - $29.40
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Purple Biotech Ltd. American Depositary Shares's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Purple Biotech Ltd. American Depositary Shares Overview

Company information

Company Overview

Purple Biotech Ltd. is a clinical-stage company, which engages in developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance. The oncology pipeline includes CM24, NT219, and CAPTN-3. The CM24 is a humanized monoclonal antibody that blocks CEACAM1, which supports tumor immune evasion and survival through multiple pathways. The NT219 is a dual inhibitor, novel small molecule that simultaneously targets IRS1/2 and STAT3. The CAPTN-3, a preclinical platform of conditionally activated tri-specific antibodies, which engage both T cells and NK cells to induce a strong, localized immune response within the tumor microenvironment. The company was founded by John Paul Waymack on August 12, 1968 and is headquartered in Rehovot, Israel.

Company Details
Market Cap
$5.95M
Shares Outstanding
1,446,783
Weighted Shares Outstanding
9,030,449
CEO
Gil Efron
Employees
7
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Purple Biotech Ltd. American Depositary Shares Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...